190 related articles for article (PubMed ID: 23591748)
21. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.
Sun Y; Qin L; Li J; Su J; Song R; Zhang X; Guan J; Mao S
AAPS J; 2021 Apr; 23(3):55. PubMed ID: 33856568
[TBL] [Abstract][Full Text] [Related]
22. Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers.
Gong QQ; Tay JYS; Veronica N; Xu J; Heng PWS; Zhang YP; Liew CV
Pharm Dev Technol; 2023 Feb; 28(2):164-175. PubMed ID: 36683577
[TBL] [Abstract][Full Text] [Related]
23. Interaction of Formulation and Device Factors Determine the In Vitro Performance of Salbutamol Sulphate Dry Powders for Inhalation.
Muddle J; Murnane D; Parisini I; Brown M; Page C; Forbes B
J Pharm Sci; 2015 Nov; 104(11):3861-3869. PubMed ID: 26220184
[TBL] [Abstract][Full Text] [Related]
24. Treating mannitol in a saturated solution of mannitol: a novel approach to modify mannitol crystals for improved drug delivery to the lungs.
Kaialy W; Nokhodchi A
Int J Pharm; 2013 May; 448(1):58-70. PubMed ID: 23500603
[TBL] [Abstract][Full Text] [Related]
25. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
Le VN; Robins E; Flament MP
Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
[TBL] [Abstract][Full Text] [Related]
26. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
[TBL] [Abstract][Full Text] [Related]
27. Characterizing the Surface Roughness Length Scales of Lactose Carrier Particles in Dry Powder Inhalers.
Tan BMJ; Chan LW; Heng PWS
Mol Pharm; 2018 Apr; 15(4):1635-1642. PubMed ID: 29490144
[TBL] [Abstract][Full Text] [Related]
28. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
Marriott C; MacRitchie HB; Zeng XM; Martin GP
Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
[TBL] [Abstract][Full Text] [Related]
29. Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.
Molina C; Kaialy W; Chen Q; Commandeur D; Nokhodchi A
Drug Deliv Transl Res; 2018 Dec; 8(6):1769-1780. PubMed ID: 29260462
[TBL] [Abstract][Full Text] [Related]
30. A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed.
Shalash AO; Elsayed MMA
AAPS PharmSciTech; 2017 Nov; 18(8):2862-2870. PubMed ID: 28421352
[TBL] [Abstract][Full Text] [Related]
31. Role of dispersion enhancer selection in the development of novel tratinterol hydrochloride dry powder inhalation formulations.
Liu T; Tong S; Liao Q; Pan L; Cheng M; Rantanen J; Cun D; Yang M
Int J Pharm; 2023 Mar; 635():122702. PubMed ID: 36773729
[TBL] [Abstract][Full Text] [Related]
32. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
[TBL] [Abstract][Full Text] [Related]
33. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
34. Effect of Roughness on the Dispersion of Dry Powders for Inhalation: a Dynamic Visualization Perspective.
Kou X; Heng PWS; Chan LW; Wereley ST; Carvajal MT
AAPS PharmSciTech; 2019 Jul; 20(7):271. PubMed ID: 31363868
[TBL] [Abstract][Full Text] [Related]
35. Performance tuning of particle engineered mannitol in dry powder inhalation formulations.
Hertel N; Birk G; Scherließ R
Int J Pharm; 2020 Aug; 586():119592. PubMed ID: 32622814
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
Jones MD; Buckton G
Int J Pharm; 2016 Jul; 509(1-2):419-430. PubMed ID: 27265314
[TBL] [Abstract][Full Text] [Related]
37. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.
Kaialy W; Ticehurst MD; Murphy J; Nokhodchi A
J Pharm Sci; 2011 Jul; 100(7):2665-84. PubMed ID: 21268026
[TBL] [Abstract][Full Text] [Related]
38. Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation.
Zeng XM; Martin GP; Tee SK; Ghoush AA; Marriott C
Int J Pharm; 1999 May; 182(2):133-44. PubMed ID: 10341303
[TBL] [Abstract][Full Text] [Related]
39. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
Kaialy W; Nokhodchi A
Pharm Res; 2013 Feb; 30(2):458-77. PubMed ID: 23070603
[TBL] [Abstract][Full Text] [Related]
40. Improving Dry Powder Inhaler Performance by Surface Roughening of Lactose Carrier Particles.
Tan BM; Chan LW; Heng PW
Pharm Res; 2016 Aug; 33(8):1923-35. PubMed ID: 27091033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
